Zimmer Biomet shoots for robot-assisted total knee release next year

zblogoZimmer Biomet (NYSE:ZBH) expects to launch a robot-assisted surgery platform for total knee procedures during the 2nd half of 2018, the company said this week at the annual conference of the American Academy of Orthopedic Surgeons in San Diego.

A prototype of the device, on display at the AOSS conference, is based on the Rosa technology Zimmer Biomet acquired when it put up $132 million for Medtech in July 2016. Montpellier, France-based Medtech developed the Rosa Brain and Rosa Spine robot-assisted surgery platforms; the Rosa Spine device won 510(k) clearance from the FDA early last year. Both Rosa systems have CE Mark approval in the European Union.

Zimmer Biomet is hoping to land 510(k) approval from the FDA for a Rosa device for total knee procedures by the 2nd half of 2018, according to Leerink Partners analyst Richard Newitter. The company will also pursue 510(k) clearance for partial knee and hip indications, Newitter wrote today in a note to investors.

By Brad Perriello | MassDevice

Image Credit: Zimmer Biomet

READ MORE

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s